Research group Mizaikoff
Mid-infrared arthroscopy innovative imaging system for real-time clinical in-depth examination and diagnosis of degenerative joint disease
MIRACLE will push towards commercialisation the first mid-infrared (MIR) arthroscopy probe for in-depth evaluation of articular cartilage enabling early diagnosis of degenerative joint diseases such as osteoarthritis (OA). The proposed device is intended for use during arthroscopy, a minimally invasive surgery. Currently, the surgeon’s decision-making is based on visual inspection and manual probing of the cartilage tissue which is highly subjective and of poor repeatability. MIRACLE concept is to assess changes to the biochemical composition of articular cartilage, which precede OA. This will be achieved combining three novel photonics components: (i) a quantum cascade laser array tailored to biodiagnostics, (ii) an on-chip beam combiner for efficient radiation coupling, and (iii) a MIR sensing probe for imaging. These components will be integrated in a medical device to be placed in the arthroscopy market. In addition, to add value to the European medical equipment industry, MIRACLE strives towards cost reduction of OA patients contributing to more affordable public healthcare and promoting well-being in the European ageing Population.
Grant agreement No 780598
sponsert by Photonics21